Latest news
Harrow acquires global rights to Tyrvaya - Optometry TimesOptometry Times · Fri, 07 Aug 2026 16:28:42 GMTFDA Recalls More than 2.5 Million Bottles of Prednisolone Acetate Eye Drops - Eyewire+Eyewire+ · Fri, 07 Aug 2026 07:00:00 GMTHarrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc. - VisionMonday.comVisionMonday.com · Fri, 07 Aug 2026 04:18:00 GMTViatris Sharpens Focus with Divestiture, Hikes 2026 Outlook - TradingViewTradingView · Thu, 06 Aug 2026 17:56:40 GMTTarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals - Eyewire+Eyewire+ · Thu, 06 Aug 2026 15:48:43 GMTHarrow Health Acquires Global Rights to TYRVAYA Nasal Spray - TipRanksTipRanks · Thu, 06 Aug 2026 13:13:25 GMTHarrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:00:00 GMTThe only FDA-approved dry-eye nasal spray is set to join Harrow later in 2026 - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMT